Unknown OBSERVATIONAL NCT03742388

A Genomic Analysis of Evolution of Epithelia Ovarian Tumors

A Genomic Analysis on the Evolution of Epithelia Ovarian Tumors

Sponsor: Lei Li

Conditions Driving Mutations Epithelial Ovarian Cancer Epithelial Ovarian Tumor of Borderline Malignancy Progression-free Survival

Updated 6 times since 2018 Last updated: Nov 13, 2018 Started: Nov 10, 2018 Primary completion: Dec 23, 2020 Completion: Dec 23, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03742388, this observational or N/A phase trial focuses on Driving Mutations and Epithelial Ovarian Cancer and remains ongoing. Sponsored by Lei Li, it has been updated 6 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Nov 2020 — Jan 2021 [monthly]

Recruiting

▶ Show 1 earlier version

Dec 2018 — Nov 2020 [monthly]

Recruiting

First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lei Li

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China